Werngard Czechtizky is Head of Medicinal Chemistry for Respiratory & Immunology at AstraZeneca. She has a track record of delivery of clinical candidates and lead compounds across several therapeutic areas (CV, Diabetes, Pain, CNS, Respiratory, Immunology). She implemented state of the art technologies into Medicinal Chemistry, e.g.ML/AI methods, New Modalities, automated synthesis and integrated physchem & eADME profiling workflows. Werngard serves on diverse scientific advisory boards, and is co-/author of ca 100 publications and patents. She has studied at the Technical University of Graz, Austria, received a PhD from ETH Zürich and a postdoctoral training at Harvard University. Before joining AZ in 2017, she has been working at Aventis, then Sanofi at Frankfurt, Germany.

Presentation Title: Navigating Multi-Party Research Partnerships - Maximize Opportunity through Effective Collaboration

View company profile